Zhimeng Biopharma EN | 简体
Zhimeng Biopharma
  • Home
  • About Us
  • People
    • Leadership Team
    • Scientific Advisors
  • Pipeline
  • News
    • News
    • Media
  • Investors
  • Join Us
  • Contact

People

Leadership Team

Huanming Chen, Ph.D.

Huanming Chen, Ph.D.

President and CEO
Zhijun Zhang, Ph.D.

Zhijun Zhang, Ph.D.

Bo Liang, Ph.D.

Bo Liang, Ph.D.

Vice President of Chemistry

Get in touch

Contact Us About Us Leadership Team Scientific Advisors
Quick Links
  • About Us
  • Contact Us
  • Join Us
  • Pipeline
  • Leadership Team
  • Scientific Advisors
Recent News
  • 挚盟医药新一代KCNQ2/3钾离子通道开放剂CB03-154获中国临床试验许可，将开启针对重度抑郁症的临床研究
  • 挚盟医药荣膺"2026年度福布斯中国行业发展领军企业"，创新药赛道再树标杆
  • Zhimeng Biopharma Successfully Holds National Investigator Meeting for Phase II/III ALS Clinical Trial of New Drug CB03-154
  • Zhimeng Biopharma's Investigational Drug Approved to Initiate Phase 2 Epilepsy Clinical Trial in China

© 2026 Zhimeng Biopharma. All Rights Reserved. 备案号:沪ICP备18045542号-1 | 沪公网安备 31011502011190号

© 2026 Zhimeng Biopharma. All Rights Reserved.